About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 320560, 11 pages
http://dx.doi.org/10.1155/2013/320560
Research Article

Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease

1The Department of Nephrology, The Third People's Hospital of Chengdu, The Chongqing Medical University, Chengdu 610031, China
2Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China
3Division of Nephrology, Department of Medicine, Columbia University Medical Center, 622 West 168th Street, PH 4-124, New York, NY 10032, USA

Received 4 April 2012; Revised 18 July 2012; Accepted 9 August 2012

Academic Editor: Sihe Wang

Copyright © 2013 Tianzhao Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tianzhao Han, Gong Rong, Dayong Quan, et al., “Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease,” BioMed Research International, vol. 2013, Article ID 320560, 11 pages, 2013. doi:10.1155/2013/320560